MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$14,524K
Proceeds from insurance
recovery - aberdeen...
$5,273K
Depreciation and
amortization
$3,594K
Accounts receivable
-$3,102K
Stock-based compensation
$1,326K
Other liabilities
$1,210K
Inventory write-off and
obsolescence
$809K
Inventories
-$723K
Provision for credit
losses
$549K
Other non-cash items
-$286K
Prepaid expenses and
other current assets
-$20K
Proceeds from sale of
assets
$152K
Net cash provided by
operating activities
$8,502K
Net cash provided by
(used in) investing...
$2,393K
Canceled cashflow
$17,641K
Canceled cashflow
$3,032K
Net change in cash
and cash...
-$5,559K
Canceled cashflow
$10,895K
Proceeds from long-term
debt
$11,000K
Accounts payable
-$5,363K
Insurance recovery on
property, plant and...
$5,273K
Accrued expenses
-$2,484K
Unearned revenues
-$1,856K
Deferred income taxes
$1,406K
Changes in value of life
insurance policies
$1,017K
Other assets
$242K
Capital expenditures -
operations
$2,006K
Capital expenditures -
rebuilding of aberdeen...
$1,024K
Patents and other
intangibles
$2K
Net cash used in
financing activities
-$16,454K
Canceled cashflow
$11,000K
Repayment of long-term
debt
$20,000K
Repurchase of common stock
$5,009K
Debt issuance costs
$1,706K
Dividends paid
$465K
Other financing
activity
-$274K
Back
Back
Cash Flow
source: myfinsight.com
Core Laboratories Inc. DE (CLB)
Core Laboratories Inc. DE (CLB)